Hematology/Oncology

Top Story

Maribavir shows promise against CMV in transplant recipients

September 18, 2019
Feature

Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

September 18, 2019
The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular therapies for cancer…
Feature

AACR Cancer Progress Report: Past federal investments in NIH spurring breakthroughs in care

September 18, 2019
The American Association for Cancer Research today released its annual Cancer Progress Report, which reflects how prior investment in the NIH is paying dividends in…
Meeting NewsPerspective

High-dose radiation effective in oligometastatic prostate cancer

September 18, 2019
Stereotactic ablative radiation appeared to be an effective and safe treatment for men with oligometastatic prostate cancer, with significant benefits observed in terms…
FDA News

FDA expands Erleada approval for prostate cancer

September 18, 2019
The FDA expanded the approval of apalutamide to include treatment of men with metastatic castration-sensitive prostate cancer. Apalutamide (Erleada, Janssen) — an…
More Headlines »
CME

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

This activity is supported by an educational grant from Merck & Co., Inc.

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly diagnosed late in the course of the disease…
More »
Video
Meeting News

VIDEO: Early steroids may reduce severe side effects among patients who receive CAR T-cell therapy

July 13, 2019
More »
Resource Centers
Discoveries from ASCO: Breast Cancer

Discoveries from ASCO: Breast Cancer

CME

Acute Lymphoblastic Leukemia Posters and Abstracts from San Diego

This activity is supported by educational funding provided by Amgen.

In this CME activity Elias Jabbour, MD, provides his perspectives on key posters presented at the American Society of…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next